Our Pipeline

Best-in-Class, Drugs for Inflammatory and Metabolic Diseases

Project

Pre-Clinical

Phase 1

Phase 2

Phase 3

ABP-671

(URAT1 inhibitor)

Gout & Hyperuricemia

Chronic Kidney Disease

Refactory Gout

ABP-745

Acute Gout

ABP-6118

(Xanthine Oxidase Inhibitor)

Gout

ABP-431

Anticancer

Learn About ABP-671 for Chronic Gout

Learn About ABP-745 for Acute Gout